| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |